The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy. - Wikidata - awgldk - TriplyDB

The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.

The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.

http://www.wikidata.org/entity/Q37784810

about

Orbital radiotherapy for adult thyroid eye disease Hypoxia increases adipogenesis and affects adipocytokine production in orbital fibroblasts-a possible explanation of the link between smoking and Graves' ophthalmopathy.Pentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts.Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.Association of IL12B polymorphisms with susceptibility to Graves ophthalmopathy in a Taiwan Chinese population.Increased microRNA-155 and decreased microRNA-146a may promote ocular inflammation and proliferation in Graves' ophthalmopathy.Rapamycin enhances TNF-α-induced secretion of IL-6 and IL-8 through suppressing PDCD4 degradation in orbital fibroblasts.CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves' orbitopathy.Essential role of connective tissue growth factor (CTGF) in transforming growth factor-β1 (TGF-β1)-induced myofibroblast transdifferentiation from Graves' orbital fibroblasts.

P2860

Q24201984-80B36CF9-6D66-47CE-A262-10853DDE3E52 Q33794950-A4ECD2F1-1674-4DF0-9C85-C077BDE9014D Q36164346-1A06E0C7-5BD6-4C22-ADD2-19C2DDB78967 Q36314821-E6F3FA9E-441B-40BA-97EC-022F9C213D97 Q36444611-E3F9FE57-477E-4AAC-BC94-14A275F3C4B5 Q37722271-408DC5EB-CE9E-41AE-9846-6B0DBCA7D36B Q44571518-7366FE41-17AF-4AA1-88DB-55A3047C04DE Q54177827-D2BE9778-D9DB-4F6D-A64B-0498794134D7 Q54960708-50D26B4B-AAE1-4234-AD0D-67066EF15B8A

P2860

The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.

http://www.wikidata.org/entity/Q37784810

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.

@en

The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.

@nl

type

label

The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.

@en

The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.

@nl

prefLabel

The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.

@en

The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.

@nl

P1433

Q37784810-343F63FD-71CB-4DF4-9110-482702E5CF45

P1476

Q37784810-DBBF6297-3907-4958-901E-FC75F88D8E78

P2093

Q37784810-0C7D1485-4175-44A3-82DF-9074AFC3202C

Q37784810-94D3A9E8-5788-4BF1-A4FF-E5A9D1F91877

P2860

Q37784810-0D7645E3-86E1-4DC3-A0CA-506E4B0D73AF

Q37784810-12D931A1-2536-40EC-A872-FE703FD8082B

Q37784810-1636F2E8-BD74-469E-A8AC-034E07E66D8A

Q37784810-2F0BEA36-96C8-4DA2-9FE6-46DAD5BD7B5E

Q37784810-37F90C35-DFCC-4091-97F6-694B43CC7BBC

Q37784810-3DB35871-C5E5-45AC-B9E6-620A120DB9E0

Q37784810-4FC99D6F-70F1-4CCA-89B9-A716C80FDDF8

Q37784810-5C5F28A0-451D-46AA-B838-B866F31E0213

Q37784810-819A8937-9F09-4794-A159-38A8F87F8307

Q37784810-8EE18197-9726-4FD1-92D4-28852F56A36A

P304

Q37784810-3241DC91-D7B9-4A85-8554-E400A68C281C

P31

Q37784810-48C97277-FADD-4059-8A40-F121454520CF

P356

Q37784810-F9B7C91C-B9B4-4CB0-AA0C-E9CC206E3C9D

P407

Q37784810-B8C4D468-57A4-4A5D-B0C0-B05E743E380F

P433

Q37784810-DF533CE4-2D97-4516-98C2-F22F15336B31

P478

Q37784810-A3DC4CB7-746F-4EBB-B763-4DEA776B7A5D

P577

Q37784810-5946429C-150F-49C8-8D61-E8A164529EF6

P698

Q37784810-12355D85-B267-4FD1-9E94-D48B65E4DFD5

P356

01676831003668443

P1433

P1476

The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.

@en

P2093

Leendert van Steensel

http://www.w3.org/2001/XMLSchema#string

Willem A Dik

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular and molecular mechanisms of fibrosis

A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts.

Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.

Diversity, topographic differentiation, and positional memory in human fibroblasts.

Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy

Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.

Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?

Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes.

Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.

Immune mechanisms in thyroid eye disease.

P304

202-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/01676831003668443

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20812837

http://www.w3.org/2001/XMLSchema#string